LakeShore Biopharma
在场
涉及LakeShore Biopharma的并购和融资。
- LakeShore Biopharma将在May 24, 2024将其名称改为LakeShore Biopharma。 (公布2024五月25号).
高管
查看带有其 18 名主要高管的组织结构图
LakeShore Biopharma 搜索最多的简介
- David Shao, Chief Executive Officer and Chief Business Officer
- Yue Pan, Director
- Yuntao Cui, Director
高管在LakeShore Biopharma变化
- Zengjun Xu已作为Director加入公司 (新闻发布的2024五月26号).
- Chunyang Shao已作为Director加入公司 (新闻发布的2024五月26号).
- Dave Chenn已作为Interim Chief Executive Officer加入公司 (新闻发布的2024五月12号).
创建提醒
跟踪 LakeShore Biopharma 的高管变动
药店
LakeShore Biopharma 拥有 1,840 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- ANI Pharmaceuticals has announced the acquisition of Alimera Sciences (公布2024六月26号).
- Sun Pharma 已收购 Taro Pharmaceutical (公布2024六月25号).
- ONO Pharmaceutical 已收购 Deciphera Pharmaceuticals (公布2024六月12号).
药店 行业的其他推荐联系人
消息
LakeShore Biopharma 的最新新闻稿
- News Releases | YS Biopharma Co., Ltd.
- YS Biopharma to Report First Nine Months of Fiscal Year 2024 Financial Results on April 19, 2024 | YS Biopharma Co., Ltd.
- News Releases | YS Biopharma Co., Ltd.
- YS Biopharma Announces Full Repayment of US$40,000,000 Loan Facility | YS Biopharma Co., Ltd.
- YS Biopharma Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies Vaccine | YS Biopharma Co., Ltd.
- YS Biopharma Announces Results of Extraordinary General Meeting held on February 22, 2024 | YS Biopharma Co., Ltd.
- YS Biopharma Announces Results of Extraordinary General Meeting and Responds to False Statements about the Meeting | YS Biopharma Co., Ltd.
- YS Biopharma Announces Board Changes and Strategic Leadership Appointments in Chinese Subsidiaries | YS Biopharma Co., Ltd.
- /C O R R E C T I O N -- YS Biopharma Co., Ltd./ | YS Biopharma Co., Ltd.
- View more press releases Close
通过电子邮件
